Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124301) titled 'Observation on the efficacy of recombinant human growth hormone combined with low-dose oral estrogen in the treatment of prepubertal Turner syndrome' on May 10.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Chengdu Women's and Children's Central Hospital
Condition:
Turner's syndrome
Intervention:
Group treated with growth hormone alone:Subcutaneous injection of growth hormone alone
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-05-13
Target Sample Size: Group treated with growth hormone alone:5;Growth hormone combined with low-dose ...